Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
Jerry S. Wolinsky,Douglas L. Arnold,Bruno Brochet,Hans-Peter Hartung,Xavier Montalbán,Robert T. Naismith,Marianna Manfrini,James Overell,Harold Koendgen,Annette Sauter,Iain Bennett,Stanislas Hubeaux,Ludwig Kappos,Stephen L. Hauser
PDF的下载单位、IP信息已删除
(2025-6-4)
cocodu
Nole
cdercder
东方元语
xing_xing
张欢馨
Kao
张开心
aajhajkahna
OK
aaaa
若一
七听
学术文献互助
乐空思
dde
Criminology34
牧青
yjh123
v0id
皖公网安备34019202002308
